|
 |
|
| |
Message From The Company |
|
|
|
A Message from Emergent BioSolutions Inc.
Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of immunobiotics, such as vaccines and immune globulins, that induce or assist the body's immune system to prevent or treat disease. Emergent's biodefense business is focused on developing and commercializing immunobiotics for use against biological agents that are potential weapons of bioterrorism. The Company's commercial business is focused on developing immunobiotics for use against infectious diseases with significant unmet or underserved medical needs. |
|
| Our Most Recent Webcast |
 |
| SYMBOL |
EVENT TITLE |
LISTEN |
DATE |
TIME (ET) |
| EBS |
Emergent BioSolutions 2013 Annual Shareholders Meeting |
 |
23-May-13 |
9:00 AM |
|
| Our Most Recent Annual Report |
|
|
